The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2014
Filed:
Feb. 22, 2006
Tushar A. Kshirsagar, Woodbury, MN (US);
Bryon A. Merrill, River Falls, WI (US);
Scott E. Langer, Woodbury, MN (US);
Kyle J. Lindstrom, Houlton, WI (US);
Sarah C. Slania, Minneapolis, MN (US);
Gregory J. Marszalek, Woodbury, MN (US);
Joshua R. Wurst, Saint Paul, MN (US);
Karl J. Manske, Minneapolis, MN (US);
Shri Niwas, Maple Grove, MN (US);
Gregory D. Lundquist, Jr., Eagan, MN (US);
Philip D. Heppner, Forrest Lake, MN (US);
George W. Griesgraber, Eagan, MN (US);
Michael E. Danielson, Saint Paul, MN (US);
Tushar A. Kshirsagar, Woodbury, MN (US);
Bryon A. Merrill, River Falls, WI (US);
Scott E. Langer, Woodbury, MN (US);
Kyle J. Lindstrom, Houlton, WI (US);
Sarah C. Slania, Minneapolis, MN (US);
Gregory J. Marszalek, Woodbury, MN (US);
Joshua R. Wurst, Saint Paul, MN (US);
Karl J. Manske, Minneapolis, MN (US);
Shri Niwas, Maple Grove, MN (US);
Gregory D. Lundquist, Jr., Eagan, MN (US);
Philip D. Heppner, Forrest Lake, MN (US);
George W. Griesgraber, Eagan, MN (US);
Michael E. Danielson, Saint Paul, MN (US);
3M Innovative Properties Company, St. Paul, MN (US);
Abstract
A method of preferentially inducing IFN-α biosynthesis in an animal comprising administering certain imidazo[4,5-c] ring compounds with a hydroxymethyl or hydroxyethyl substituent at the 2-position or pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of using these compounds a immunomodulators for treatment of diseases including viral and neoplastic diseases comprising preferentially inducing IFN-α biosynthesis in an animal are disclosed.